Balanced Pharma
About this raise
Balanced Pharma is raising funds on Dalmore Group through Reg A+ crowdfunding. The company intends to develop and sell a drug named Libracaine Dental. It is a pH-balanced injectable local anesthetic to be used for dental procedures. The drug is in the development phase and will be used to save time for dentists, reduce pain for patients, and improve the patient experience. J. Scott Keadle founded Balanced Pharma in 2020. The current crowdfunding campaign has no minimum target and a maximum target of $25,000,000. The campaign proceeds will be used for product development, product manufacturing, product marketing and disease awareness, intellectual property development, and general and administrative purposes.
Investment Overview
Invested $572,572 :
Deal Terms
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $2,000,000
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
10/31/2023 | Dalmore Group | $82,440,000 | $572,572 | Equity - Common | Funded | RegA+ |